| Molecular Formula | C20H15NO3 |
| Molar Mass | 317.338 |
| Density | 1.289±0.06 g/cm3(Predicted) |
| Melting Point | 272 °C |
| Boling Point | 464.4±38.0 °C(Predicted) |
| Solubility | DMSO: ≥ 42 mg/mL |
| Appearance | powder |
| Color | White |
| pKa | 3.45±0.36(Predicted) |
| Storage Condition | room temp |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
| Physical and Chemical Properties | Bioactive Kartogenin (KGN) is a smad4/smad5 pathway activator, which promotes the selective differentiation of multifunctional mesenchymal stem cells into chondrocytes. |
| Risk Codes | R22 - Harmful if swallowed R36 - Irritating to the eyes R50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. |
| Safety Description | S60 - This material and its container must be disposed of as hazardous waste. S61 - Avoid release to the environment. Refer to special instructions / safety data sheets. |
| UN IDs | UN 3077 9 / PGIII |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 3.151 ml | 15.756 ml | 31.512 ml |
| 5 mM | 0.63 ml | 3.151 ml | 6.302 ml |
| 10 mM | 0.315 ml | 1.576 ml | 3.151 ml |
| 5 mM | 0.063 ml | 0.315 ml | 0.63 ml |
Target
Target Value
Smad4
Smad5
in vitro studies
Kartogenin induced hMSCs to differentiate into chondrocytes and protected articular chondrocytes by enhancing CBFβ nuclear localization. Kartogenin promotes type I collagen synthesis of dermal fibroblasts by activating the smad4/smad5 pathway without significant cytotoxicity to the activity, morphology and survival of fibroblasts.
In vivo studies
In mouse models of OA caused by collagenase VII (10 μM)-and surgical (100 μM)-Kartogenin promote cartilage repair. Kartogenin (100 nM) also stimulates collagen synthesis in mouse dermis. In addition, Kartogenin stimulated bone growth and synovial joint development in mouse limbs.